Genetic Studies of Early-onset Dementia
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT04906863
- Status
- Recruiting
Conditions
- Alzheimer Dementia (AD)
- Dementia, Early Onset
- Memory Loss
- Mild Cognitive Impairment (MCI)
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Blood draw — GENETICBlood draw for identification of genetic variants associated with the development of memory problems
- Neurocognitive testing — OTHERBrief memory test
- Medical questionnaire — OTHERCollection of medical history
Study Details
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Key Dates
- Start date
- Sep 14, 2016
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Mild Cognitive ImpairmentIndividuals with mild cognitive impairment that began before age 70
- Arm: Dementia/Alzheimer's DiseaseIndividuals with Alzheimer's Disease or other dementia that began before age 70
- Arm: Cognitively HealthyCognitively healthy individuals over the age of 35 years with a family history of dementia.
- Arm: Early-onset dementia prior to the age of 65.Individuals diagnosed with early-onset dementia prior to the age of 65.
Primary Outcome Measure
Genetic risk variants associated with early-onset dementia [ Time Frame: 2 years ]
Central Contacts
- Pamela Del Rosario212-304-7284
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | Christiane Reitz, MD PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site
Related Studies
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaRecruiting · GAP Innovations, PBC · Atlantis, Florida
- Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 TrialPHASE2 · Recruiting · Columbia University · Miami, Florida
- Memory Support System for Older Chinese Americans With Mild Cognitive ImpairmentRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive ImpairmentNot Yet Recruiting · Albert Einstein College of Medicine · The Bronx, New York